TY - BOOK PY - 2013 DA - 2013// TI - Global Tuberculosis Report 2013 PB - World Health Organization (WHO/HTM/TB/2013.11) CY - Geneva ID - ref1 ER - TY - STD TI - World Health Organization. Revised definitions and reporting framework for tuberculosis - 2013 revision. Geneva: World Health Organization (WHO/HTM/TB/2013.2); 2013. ID - ref2 ER - TY - JOUR AU - Tukvadze, N. AU - Bablishvili, N. AU - Apsindzelashvili, R. AU - Blumberg, H. M. AU - Kempker, R. R. PY - 2014 DA - 2014// TI - Performance of the MTBDRsl assay in Georgia JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.13.0468 DO - 10.5588/ijtld.13.0468 ID - Tukvadze2014 ER - TY - JOUR AU - Tukvadze, N. AU - Kempker, R. R. AU - Kalandadze, I. AU - Kurbatova, E. AU - Leonard, M. K. AU - Apsindzelashvili, R. PY - 2012 DA - 2012// TI - Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031563 DO - 10.1371/journal.pone.0031563 ID - Tukvadze2012 ER - TY - STD TI - Barnard M, Warren R, Gey Van Pittius N, van Helden P, Bosman M, Streicher E, et al. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. Am J Respir Crit Care Med. 2012;186(12):1298–305. ID - ref5 ER - TY - STD TI - World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update. Geneva: World Health Organization (WHO/HTM/TB/2011.6); 2011. ID - ref6 ER - TY - JOUR AU - Bonnet, M. AU - Pardini, M. AU - Meacci, F. AU - Orru, G. AU - Yesilkaya, H. AU - Jarosz, T. PY - 2011 DA - 2011// TI - Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0023081 DO - 10.1371/journal.pone.0023081 ID - Bonnet2011 ER - TY - JOUR AU - Bergval, I. AU - Sengstake, S. AU - Brankova, N. AU - Levterova, V. AU - Abadia, E. AU - Tadumaze, N. PY - 2012 DA - 2012// TI - Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by MLPA on a bead-based array. 1 JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0043240 DO - 10.1371/journal.pone.0043240 ID - Bergval2012 ER - TY - JOUR AU - Theron, G. AU - Peter, J. AU - Richardson, M. AU - Barnard, M. AU - Donegan, S. AU - Warren, R. PY - 2014 DA - 2014// TI - The diagnostic accuracy of the GenoType((R)) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs JO - Cochrane Database Syst Rev VL - 10 ID - Theron2014 ER - TY - JOUR AU - Saah, A. J. AU - Hoover, D. R. PY - 1997 DA - 1997// TI - “Sensitivity” and “specificity” reconsidered: the meaning of these terms in analytical and diagnostic settings JO - Ann Intern Med VL - 126 UR - https://doi.org/10.7326/0003-4819-126-1-199701010-00026 DO - 10.7326/0003-4819-126-1-199701010-00026 ID - Saah1997 ER - TY - BOOK PY - 2014 DA - 2014// TI - Tuberculosis surveillance and monitorin in Europe 2013 PB - European Centre for Disease Prevention and Control CY - Stockholm ID - ref11 ER - TY - JOUR AU - Pardini, M. AU - Niemann, S. AU - Varaine, F. AU - Iona, E. AU - Meacci, F. AU - Orru, G. PY - 2009 DA - 2009// TI - Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe JO - Tuberculosis (Edinb) VL - 89 UR - https://doi.org/10.1016/j.tube.2009.04.002 DO - 10.1016/j.tube.2009.04.002 ID - Pardini2009 ER - TY - JOUR AU - Mitnick, C. D. AU - Shin, S. S. AU - Seung, K. J. AU - Rich, M. L. AU - Atwood, S. S. AU - Furin, J. J. PY - 2008 DA - 2008// TI - Comprehensive treatment of extensively drug-resistant tuberculosis JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0800106 DO - 10.1056/NEJMoa0800106 ID - Mitnick2008 ER - TY - JOUR AU - Lee, M. AU - Lee, J. AU - Carroll, M. W. AU - Choi, H. AU - Min, S. AU - Song, T. PY - 2012 DA - 2012// TI - Linezolid for treatment of chronic extensively drug-resistant tuberculosis JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1201964 DO - 10.1056/NEJMoa1201964 ID - Lee2012 ER - TY - JOUR AU - Holtz, T. H. AU - Sternberg, M. AU - Kammerer, S. AU - Laserson, K. F. AU - Riekstina, V. AU - Zarovska, E. PY - 2006 DA - 2006// TI - Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome JO - Ann Intern Med VL - 144 UR - https://doi.org/10.7326/0003-4819-144-9-200605020-00008 DO - 10.7326/0003-4819-144-9-200605020-00008 ID - Holtz2006 ER - TY - BOOK PY - 2008 DA - 2008// TI - Guidelines for the programmatic management of drug-resistant tuberculosis, Emergency update, 2008 PB - World Health Organization CY - Geneva ID - ref16 ER - TY - JOUR AU - Lu, C. AU - Liu, Q. AU - Sarma, A. AU - Fitzpatrick, C. AU - Falzon, D. AU - Mitnick, C. D. PY - 2013 DA - 2013// TI - A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0056074 DO - 10.1371/journal.pone.0056074 ID - Lu2013 ER - TY - JOUR AU - Vassall, A. AU - Kampen, S. AU - Sohn, H. AU - Michael, J. S. AU - John, K. AU - Boon, S. PY - 2011 DA - 2011// TI - Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis JO - PLoS Med VL - 8 UR - https://doi.org/10.1371/journal.pmed.1001120 DO - 10.1371/journal.pmed.1001120 ID - Vassall2011 ER - TY - JOUR AU - Knight, G. M. AU - Griffiths, U. K. AU - Sumner, T. AU - Laurence, Y. V. AU - Gheorghe, A. AU - Vassall, A. PY - 2014 DA - 2014// TI - Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1404386111 DO - 10.1073/pnas.1404386111 ID - Knight2014 ER - TY - STD TI - Gunther G, Gomez GB, Lange C, Rupert S, van Leth F. Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey. Eur Respir J. 2014;13. ID - ref20 ER - TY - JOUR AU - Fitzpatrick, C. AU - Floyd, K. PY - 2012 DA - 2012// TI - A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis JO - Pharmacoeconomics VL - 30 UR - https://doi.org/10.2165/11595340-000000000-00000 DO - 10.2165/11595340-000000000-00000 ID - Fitzpatrick2012 ER - TY - STD TI - The World Bank. GDP deflator. 2014. 23-4-0014. 2014. http://data.worldbank.org/indicator/NY.GDP.DEFL.ZS. Date accessed: 23-04-2014. UR - http://data.worldbank.org/indicator/NY.GDP.DEFL.ZS ID - ref22 ER - TY - JOUR AU - Rodwell, T. C. AU - Valafar, F. AU - Douglas, J. AU - Qian, L. AU - Garfein, R. S. AU - Chawla, A. PY - 2014 DA - 2014// TI - Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations JO - J Clin Microbiol VL - 52 UR - https://doi.org/10.1128/JCM.02701-13 DO - 10.1128/JCM.02701-13 ID - Rodwell2014 ER - TY - STD TI - World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization (WHO/HTM/TB/2014.11); 2014. ID - ref24 ER - TY - JOUR AU - Jacobson, K. R. AU - Tierney, D. B. AU - Jeon, C. Y. AU - Mitnick, C. D. AU - Murray, M. B. PY - 2010 DA - 2010// TI - Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/653115 DO - 10.1086/653115 ID - Jacobson2010 ER - TY - JOUR AU - Falzon, D. AU - Gandhi, N. AU - Migliori, G. B. AU - Sotgiu, G. AU - Cox, H. S. AU - Holtz, T. H. PY - 2013 DA - 2013// TI - Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00134712 DO - 10.1183/09031936.00134712 ID - Falzon2013 ER - TY - JOUR AU - Dowdy, D. W. AU - Hoog, A. AU - Shah, M. AU - Cobelens, F. PY - 2014 DA - 2014// TI - Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.13.0776 DO - 10.5588/ijtld.13.0776 ID - Dowdy2014 ER - TY - JOUR AU - Bwanga, F. AU - Hoffner, S. AU - Haile, M. AU - Joloba, M. L. PY - 2009 DA - 2009// TI - Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis JO - BMC Infect Dis VL - 9 UR - https://doi.org/10.1186/1471-2334-9-67 DO - 10.1186/1471-2334-9-67 ID - Bwanga2009 ER - TY - BOOK PY - 2012 DA - 2012// TI - Tuberculosis surveillance and monitorin in Europe 2011 PB - European Centre for Disease Prevention and Control CY - Stockholm ID - ref29 ER - TY - JOUR AU - Steingart, K. R. AU - Sohn, H. AU - Schiller, I. AU - Kloda, L. A. AU - Boehme, C. C. AU - Pai, M. PY - 2014 DA - 2014// TI - Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (updated) JO - Cochrane Database Syst Rev VL - 1 ID - Steingart2014 ER - TY - JOUR AU - Hertog, A. L. AU - Daher, S. AU - Straetemans, M. AU - Scholing, M. AU - Anthony, R. M. PY - 2013 DA - 2013// TI - No added value of performing Ziehl-Neelsen on auramine-positive samples for tuberculosis diagnostics JO - Int J Tuberc Lung Dis VL - 17 UR - https://doi.org/10.5588/ijtld.12.0773 DO - 10.5588/ijtld.12.0773 ID - Hertog2013 ER - TY - JOUR AU - Rabin, A. S. AU - Kuchukhidze, G. AU - Sanikidze, E. AU - Kempker, R. R. AU - Blumberg, H. M. PY - 2013 DA - 2013// TI - Prescribed and self-medication use increase delays in diagnosis of tuberculosis in the country of Georgia JO - Int J Tuberc Lung Dis VL - 17 UR - https://doi.org/10.5588/ijtld.12.0395 DO - 10.5588/ijtld.12.0395 ID - Rabin2013 ER - TY - JOUR AU - Conde, M. B. AU - Efron, A. AU - Loredo, C. AU - Souza, G. R. AU - Graca, N. P. AU - Cezar, M. C. PY - 2009 DA - 2009// TI - Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60333-0 DO - 10.1016/S0140-6736(09)60333-0 ID - Conde2009 ER - TY - JOUR AU - Gonzalez-Montaner, L. J. AU - Natal, S. AU - Yongchaiyud, P. AU - Olliaro, P. PY - 1994 DA - 1994// TI - Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin, Rifabutin Study Group JO - Tuber Lung Dis VL - 75 UR - https://doi.org/10.1016/0962-8479(94)90079-5 DO - 10.1016/0962-8479(94)90079-5 ID - Gonzalez-Montaner1994 ER - TY - JOUR AU - Fortun, J. AU - Martin-Davila, P. AU - Molina, A. AU - Navas, E. AU - Hermida, J. M. AU - Cobo, J. PY - 2007 DA - 2007// TI - Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? JO - J Antimicrob Chemother VL - 59 UR - https://doi.org/10.1093/jac/dkm025 DO - 10.1093/jac/dkm025 ID - Fortun2007 ER - TY - BOOK PY - 2012 DA - 2012// TI - Global Tuberculosis Control: WHO Report 2012 PB - World Health Organization (WHO/HTM/TB/2012.6) CY - Geneva ID - ref36 ER -